GrowBLOX Sciences, Inc. Announces New Headquarters in Nevada

LAS VEGAS, May 30, 2014 /PRNewswire/ -- GrowBLOX Sciences, Inc. (OTCQB: GBLX) a biotechnology and research company, announced today that The Company has relocated its corporate headquarters to Las Vegas, Nevada and has centralized its CFO and team in the heart of Clark County in anticipation of its Nevada project. 

GrowBLOX Sciences CFO, Steven Weldon, has relocated from Orlando, Florida to Clark County in order to build upon the momentum of The Company's licensing applications, as it awaits final approval from the County Commission.  GrowBLOX Sciences has applied for three licenses in Clark County, one license for cultivation and two licenses for dispensaries, utilizing their patent pending proprietary indoor growing technology.  The Company is confident in its Nevada initiatives and has relocated its forces as a driving catalyst for their future operations.  

"Relocating to Nevada has been an exciting endeavor for not only myself, but The Company as well.  Nevada has been the preeminent force in licensing and regulatory commissions for sometime and has a proven record of success.  Working with the local municipalities in Clark County is a driving force in moving this processes forward and we are thrilled to be a part of it and set the standard for innovation and cultivation," said CFO, Steven Weldon.

GrowBLOX Sciences is continuing to broaden its corporate functions alongside its Nevada projects, as The Company streamlines its initiatives in accordance with all state and county laws and regulations.  By relocating to Clark County, GrowBLOX Sciences plans to facilitate and expedite its position at the front lines of this emerging industry.

About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed proprietary indoor growing chambers specifically designed for medical cannabis cultivation.  The GrowBLOX chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product.  The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions.  http://www.gbsciences.com

Forward-Looking Statements
Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements are inherently unreliable and actual results may differ materially.  Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results.  Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company's ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission.  The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Craig Ellins
CEO, GrowBLOX Sciences, Inc.
+1-844-843-BLOX ext. 01

SOURCE GrowBLOX Sciences, Inc.